1. Home
  2. FLY vs PTGX Comparison

FLY vs PTGX Comparison

Compare FLY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$18.92

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$131.73

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
PTGX
Founded
2017
2006
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.5B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
FLY
PTGX
Price
$18.92
$131.73
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$38.88
$108.23
AVG Volume (30 Days)
4.9M
761.7K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
N/A
Revenue This Year
$174.79
$874.25
Revenue Next Year
$66.73
N/A
P/E Ratio
N/A
$2,730.00
Revenue Growth
N/A
N/A
52 Week Low
$16.00
$50.49
52 Week High
$62.17
$141.10

Technical Indicators

Market Signals
Indicator
FLY
PTGX
Relative Strength Index (RSI) 28.00 60.69
Support Level $18.07 $94.48
Resistance Level $21.93 $141.10
Average True Range (ATR) 2.02 6.14
MACD -0.41 -0.37
Stochastic Oscillator 1.22 58.96

Price Performance

Historical Comparison
FLY
PTGX

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: